Corporate Development Director Strategy M&A AI

Company Description

Guardant Health is a leading precision oncology company focused on guarding wellness and giving every person more time free from cancer. Founded in 2012 Guardant is transforming patient care and accelerating new cancer therapies by providing critical insights into what drives disease through its advanced blood and tissue tests real-world data and AI analytics. Guardant tests help improve outcomes across all stages of care including screening to find cancer early monitoring for recurrence in early-stage cancer and treatment selection for patients with advanced cancer. For more information visitand follow the company onLinkedInX (Twitter)andFacebook.

Guardant Healths Corporate Development group is responsible for license partnership and acquisition strategy development and execution long-range planning and strategy and business intelligence insights.

The group operates through advisement to the Guardant Health Investment Committee to set and execute traditional M&A partnership and investment addition this group facilitates the Companys long-range planning process by guiding each function through key questions each year and ensuring quality control in advance of leadership approval. Business intelligence and insights are integral to these responsibilities.

Our Corporate Development Director- Strategy / M&A / AI will support all aspects of Guardant Healths Corporate Development function. The role requires a self-starter with strong analytical financial and strategic skills as well as the ability to synthesize complex data into clear actionable recommendations for leadership. The successful candidate will help shape Guardants corporate development strategy by identifying industry trends maintaining relationships with external partners and sourcing negotiating structuring and executing strategic acquisitions and investments across the Companys geographies and businesses. The role will also contribute to the development of new business models and decision frameworks that leverage advanced analytics and emerging technologies to improve strategic insight and execution. Adaptability and strategic agility are essential in Guardants fast-evolving competitive environment.

Essential Duties and Responsibilities

Lead the transaction due diligence process incorporating data analytics and intelligent automation to streamline evaluation and improve decision accuracy.
Develop business cases supported by advanced market valuation and financial analytics including scenario modeling and trend forecasting.
Support the Companys growth strategy through the identification assessment and execution of M&A investments and partnerships guided by data-driven insights and predictive intelligence.
Maintain and refine structured processes to identify and evaluate strategic opportunities across multiple business areas integrating both quantitative and qualitative assessments.
Collaborate with business leaders to identify and prioritize opportunities in a systematic and informed manner ensuring alignment with each units objectives and long-term plans.
Build and maintain strong relationships across business units to sustain an ongoing flow of high-quality strategic ideas and partnership opportunities.
Partner with business leaders before during and after M&A activity to ensure strategic fit long-term value creation and smooth post-deal integration.
Support cross-functional teams in developing acquisition business cases and executing transactions coordinating with Finance Accounting Legal Tax HR and other departments to ensure seamless diligence and execution.
Continuously enhance analytical capabilities incorporating modern data platforms automation and AI-enabled tools to improve sourcing valuation and post-merger performance tracking.

Essential Qualifications

8 years of experience in Corporate Development or M&A at a comparable healthcare company or Investment Bank. Experience in Product R&D or Marketing a plus.
Undergraduate business degree MBA or PhD degree with a technical background in genomics therapeutics or oncology preferred.
Demonstrated M&A partnering and equity investment experience including negotiation execution and transaction closing.
Intermediate or advanced understanding of the biotech diagnostic or medical device industry.
Strong analytical and problem-solving skills with experience using modern data analytics automation and AI-assisted decision tools to support strategy and valuation work.
Ability to structure and manage complex projects and processes with multiple stakeholders at all levels including Executive and senior leadership.
Excellent communication and presentation skills with the ability to convey data-driven insights clearly and persuasively.
Ability to travel both domestically and internationally 10%20% to conferences and meetings.

Hybrid Work Model: This section is applicable to onsite employees who are eligible for hybrid work location as specified by management and related policies. Guardant has defined days for in-person/onsite collaboration and work-from-home days for individual-focused time. All U.S. employees who live within 50 miles of a Guardant facility will be required to be onsite on Mondays Tuesdays and Thursdays. We have found aligning our scheduled in-office days allows our teams to do the best work and creates the focused thinking time our innovative work requires. At Guardant our work model has created flexibility for better work-life balance while keeping teams connected to advance our science for our patients.